Eternit S.A. (BVMF:ETER3)

Blueprint Medicines Income Statement

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,179	1,162	1,129	1,187	1,123	683.42
Revenue Growth (YoY)	7.20%	2.88%	-4.90%	5.72%	64.34%	39.85%
Cost of Revenue	945.01	913.94	838.41	815.44	632.08	456.08
Gross Profit	233.54	247.81	290.8	371.94	491.05	227.34
Selling, General & Admin	214.05	212.52	212.19	210.51	191	142.82
Other Operating Expenses	-11.31	-11.54	-9.01	-3.64	-14.74	-37.04
Operating Expenses	202.74	200.98	203.17	206.87	176.25	105.78
Operating Income	30.8	46.83	87.63	165.07	314.8	121.56
Interest Expense	-23.82	-17.95	-14.68	-9.48	-7.62	-14.57
Interest & Investment Income	-	2.06	5.84	16.14	10.27	1.13
Currency Exchange Gain (Loss)	-1.2	0.63	-0.21	-13.06	0.31	-0.8
Other Non Operating Income (Expenses)	1.27	-3.9	-2.88	-5.2	-1.58	19.28
EBT Excluding Unusual Items	7.06	27.67	75.7	153.47	316.17	126.6
Merger & Restructuring Charges	-	-	-	-0.78	-	-
Gain (Loss) on Sale of Assets	20.5	20.5	0.37	18.45	18.5	2.76
Asset Writedown	-23.6	-23.6	-0.97	-6.09	5.65	71.63
Legal Settlements	1.84	0.58	-4.06	-0.04	6.71	-6.03
Other Unusual Items	-7.5	-7.5	-8.07	-	-	-1.3
Pretax Income	-1.71	17.65	62.96	165	347.02	193.65
Income Tax Expense	-29.53	-21.18	-64.26	27.29	77.58	34.92
Earnings From Continuing Operations	27.83	38.82	127.22	137.71	269.45	158.73
Minority Interest in Earnings	-0.05	-0.05	-0.04	-0.11	-0.07	0.02
Net Income	27.78	38.77	127.18	137.6	269.38	158.75
Net Income to Common	27.78	38.77	127.18	137.6	269.38	158.75
Net Income Growth	-73.65%	-69.52%	-7.57%	-48.92%	69.69%	-
Shares Outstanding (Basic)	62	62	62	62	62	52
Shares Outstanding (Diluted)	62	62	62	62	62	52
Shares Change (YoY)	0.23%	-0.12%	-0.07%	-	19.55%	62.66%
EPS (Basic)	0.45	0.63	2.06	2.23	4.36	3.07
EPS (Diluted)	0.45	0.63	2.06	2.23	4.36	3.07
EPS Growth	-73.72%	-69.48%	-7.51%	-48.92%	41.94%	-
Free Cash Flow	33.15	59.12	-122.98	38.04	77.57	77.08
Free Cash Flow Per Share	0.54	0.96	-1.99	0.62	1.26	1.49
Dividend Per Share	0.126	0.289	0.336	0.609	0.635	-
Dividend Growth	-70.16%	-14.03%	-44.84%	-4.12%	-	-
Gross Margin	19.82%	21.33%	25.75%	31.32%	43.72%	33.27%
Operating Margin	2.61%	4.03%	7.76%	13.90%	28.03%	17.79%
Profit Margin	2.36%	3.34%	11.26%	11.59%	23.98%	23.23%
Free Cash Flow Margin	2.81%	5.09%	-10.89%	3.20%	6.91%	11.28%
EBITDA	79.77	94.85	123.43	185.65	329.14	139.29
EBITDA Margin	6.77%	8.16%	10.93%	15.63%	29.31%	20.38%
D&A For EBITDA	48.97	48.02	35.8	20.58	14.34	17.73
EBIT	30.8	46.83	87.63	165.07	314.8	121.56
EBIT Margin	2.61%	4.03%	7.76%	13.90%	28.03%	17.79%
Effective Tax Rate	-	-	-	16.54%	22.36%	18.03%
Advertising Expenses	-	2.88	2.45	1.95	2.56	1.08

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.